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Apaf-1 plays a critical role in apoptosis by binding to
and activating procaspase-9. We have identified a novel
Apaf-1 cDNA encoding a protein of 1248 amino acids
containing an insertion of 11 residues between the
CARD and ATPase domains, and another 43 amino
acid insertion creating an additional WD-40 repeat.
The product of this Apaf-1 cDNA activated procaspase-
9 in a cytochrome c and dATP/ATP-dependent manner.
We used this Apaf-1 to show that Apaf-1 requires
dATP/ATP hydrolysis to interact with cytochrome c,
self-associate and bind to procaspase-9. A P-loop
mutant (Apaf-1K160R) was unable to associate with
Apaf-1 or bind to procaspase-9. Mutation of Met368
to Leu enabled Apaf-1 to self-associate and bind
procaspase-9 independent of cytochrome c, though
still requiring dATP/ATP for these activities. The
Apaf-1M368L mutant exhibited greater ability to
induce apoptosis compared with the wild-type Apaf-1.
We also show that procaspase-9 can recruit procaspase-
3 to the Apaf-1–procaspase-9 complex. Apaf-1(1–570),
a mutant lacking the WD-40 repeats, associated with
and activated procaspase-9, but failed to recruit
procaspase-3 and induce apoptosis. These results
suggest that the WD-40 repeats may be involved
in procaspase-9-mediated procaspase-3 recruitment.
These studies elucidate biochemical steps required for
Apaf-1 to activate procaspase-9 and induce apoptosis.
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Introduction
Programmed cell death, or apoptosis, an evolutionarily
conserved and genetically regulated biological process,
plays a critical role in the development and the regula-
tion of tissue homeostasis of multicellular organisms
(Thompson, 1995; Yuan, 1996). Genetic analyses of the
nematode Caenorhabditis elegans have identified two
genes, ced-3 and ced-4, required for the execution of
cell death in the worm (Hengartner and Horvitz, 1994).
The product of ced-3 is homologous to mammalian
interleukin-1β-converting enzyme, a finding that provided
the first indication that cysteine proteases are critical
components of the cell death machinery (Miura et al.,
1993). These observations led to the identification of
a growing family of cysteine proteases (designated as
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caspases) related to CED-3 that represent the executionary
arm of the apoptotic program in mammals, flies and
nematodes (Núñez et al., 1998; Thornberry and Labzenik,
1998). Caspases are synthesized in cells as inactive pre-
cursors which upon stimulation with apoptotic signals are
processed into mature forms composed of a tetramer of
two large and two small subunits (Thornberry et al., 1992;
Walker et al., 1994; Rotonda et al., 1996). The apoptotic
process is characterized by the proteolytic cascade in
which upstream (initiator) caspases mediate the activation
of downstrean (effector) caspases (Alnemri, 1997; Núñez
et al., 1998). Initiator caspases contain death effector
domains (DEDs) or caspase recruitment domains (CARDs)
that physically link these proteases to regulatory molecules
via homophilic interactions (Li et al., 1997; Pan et al.,
1998). Caspase-9 is an upstream caspase that contains a
CARD in its N-terminus; a protein module that is also
present in the prodomain of several death proteases,
including CED-3 and its regulator CED-4 (Hofmann et al.,
1997). Activation of caspase-9 initiates a protease cascade
that subsequently activates downstream caspase-3 and
caspase-7, leading to the cleavage of target proteins and
the orderly demise of the cell (Li et al., 1997; Sun
et al., 1999).
Our understanding of how caspases are activated in
mammalian cells has been greatly enhanced by bio-
chemical studies of the nematode proteins CED-3, CED-4
and CED-9. CED-4 physically interacts with both CED-3
and CED-9, forming a multimeric protein complex
(Chinnaiyan et al., 1997; Irmler et al., 1997; James et al.,
1997; Spector et al., 1997; Wu et al., 1997a,b). CED-4
promotes the activation of CED-3 and this activation
process is inhibited by CED-9 (Seshagiri and Miller,
1997; Wu et al., 1997b). Biochemical experiments have
suggested that a mechanism exists whereby CED-3 is
activated through oligomerization of CED-4 (Yang et al.,
1998). Activation of CED-3 is induced through
aggregation of precursor CED-3 molecules, an event
leading to CED-3 autoprocessing and enzymatic activation
(Yang et al., 1998).
Apaf-1, a mammalian homologue of CED-4, has been
identified recently (Zou et al., 1997; Fearnhead et al.,
1998). The N-terminal half of Apaf-1 shares extensive
homology with CED-4, containing a CARD followed by
an ATPase domain with conserved Walker’s A and B
motifs (Zou et al., 1997). The C-terminal region of Apaf-1
lacks homology with CED-4 and consists of 12 WD-40
repeats. An important role for Apaf-1 in the regulation of
apoptosis has been revealed by analysis of mutant mice
deficient in Apaf-1. Mice lacking Apaf-1 showed abnor-
malities in several tissues characterized by the lack of
developmental cell death, particularly in brain tissue
(Cecconi et al., 1998; Yoshida et al., 1998). Furthermore,
cells derived from Apaf-1-deficient mice showed resist-
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ance to a wide variety of apoptotic stimuli, including
chemotherapy drugs, dexamethasone and γ-irradiation
(Yoshida et al., 1998). In the presence of cytochrome c
and dATP, Apaf-1 adopts a conformation that can bind to
procaspase-9, an event that leads to its proteolytic activa-
tion (Li et al., 1997). A conserved mechanism similar to
that proposed for CED-3 has been suggested for caspase-9
activation (Hu et al., 1998b; Srinivasula et al., 1998). In
this model, two or more caspase-9 precursors are brought
together via Apaf-1 oligomerization, which is mediated
by the ATPase-like domain of Apaf-1 (Hu et al., 1998b;
Srinivasula et al., 1998). Mutant analyses of Apaf-1 have
suggested that the WD-40 repeat region (WDR) plays an
inhibitory role in Apaf-1 function, since mutants lacking
the WDR are constitutively active (Hu et al., 1998a,b;
Srinivasula et al., 1998). Furthermore, the WDR has been
shown to interact with the ATPase-like domain of
Apaf-1, inhibiting Apaf-1 self-association. This finding
suggests the existence of a mechanism whereby the WDR
inhibits Apaf-1 activity (Hu et al., 1998b).
In these studies, we sought to understand further the
biochemical mechanism by which Apaf-1 promotes the
maturation of procaspase-9 into an active protease. Ana-
lysis of wild-type (wt) and mutant Apaf-1 proteins revealed
that dATP/ATP hydrolysis is required for cytochrome c
binding to Apaf-1, Apaf-1 self-association, interaction of
Apaf-1 with procaspase-9, and ultimately for caspase-9
activation and caspase-9-mediated apoptosis. We also
provide evidence that the Apaf-1–caspase-9 complex
recruits procaspase-3, a process that may be regulated by
the WDR of Apaf-1.
Results
Identification of Apaf-1XL, an alternatively spliced
Apaf-1 cDNA that activates procaspase-9
In our initial studies of Apaf-1-mediated caspase-9 activa-
tion, we determined that procaspase-9 could be efficiently
activated by endogenous Apaf-1 from several cell lines
including HeLa and 293T cells (Hu et al., 1998a; data
not shown). We subsequently identified Apaf-1 cDNAs
from these two cell lines. An Apaf-1 cDNA cloned from
HeLa cells was identical to that previously reported (Zou
et al., 1997). However, the Apaf-1 cDNA cloned from
293T cells appeared to represent an alternatively spliced
form of the Apaf-1 gene. This form, termed Apaf-1XL,
contains an 11 amino acid (aa) insertion, GKDSVSGITSY,
after the CARD (inserted between amino acids 98 and
99), and another 43 aa insertion between amino acids 811
and 812 (Figure 1A). This 43 aa region contains the last
three amino acids of a WD-40 repeat followed by a
large portion of another WD-40 repeat, thus creating an
additional WD-40 repeat (Figure 1A). The sequence of
these extra 43 aa is identical to that present in a truncated
human Apaf-1 cDNA submitted to databases (DDBJ/
EMBL/GenBank accession No. AB007873). Moreover, a
mouse Apaf-1 cDNA isolated from brain tissue also
contained this additional WD-40 repeat (Cecconi et al.,
1998). In addition, a recent study has identified an Apaf-1
form in HeLa cells that is identical to Apaf-1XL (Zou
et al., 1999). Using reverse transcriptase (RT)–PCR and
Western blotting analysis, we have identified both Apaf-
1XL mRNA and protein in 16 cell lines tested so far (data
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not shown). Under our experimental conditions, Apaf-1XL
protein expressed in 293T cells activated procaspase-9 in
a cytochrome c- and dATP-dependent manner (Figure 1D).
Under the same conditions, we were unable to demonstrate
cytochrome c- and dATP-dependent procaspase-9 activa-
tion by the product of the original Apaf-1 cDNA (data
not shown). Therefore, in the present studies we used the
Apaf-1XL cDNA to examine the mechanism by which
Apaf-1 activates procaspase-9 and refer to it as Apaf-1
for simplicity.
Mutation of Met368 to Leu enables full-length
Apaf-1 to activate procaspase-9 independently of
cytochrome c and dATP
We demonstrated previously that the WDR interacts with
the N-terminal CED-4 homologous region of Apaf-1 and
inhibits procaspase-9 activation when co-expressed with
the constitutively active N-terminal Apaf-1 mutants (Hu
et al., 1998b). We performed experiments to determine
whether the WDR with an extra WD-40 repeat is also
capable of binding to N-terminal Apaf-1 with an 11 aa
insertion [Apaf-1(1–570)] and inhibiting procaspase-9
activation. The analyses showed that the WDR containing
the extra WD-40 repeat associated with Apaf-1(1–570)
(Figure 1B) and inhibited procaspase-9 activation pro-
moted by Apaf-1(1–570) (Figure 1C). To understand
further how Apaf-1 promotes procaspase-9 activation, we
tested several Apaf-1 N-terminal mutants accumulated
during PCR mutagenesis for their ability to interact with
the WDR. A mutant substituting amino acid Met368
for Leu, Apaf-1(1–570M368L), showed a reduced
ability to bind the WDR (Figure 1B), but it retained its
ability to promote procaspase-9 activation independent of
cytochrome c and dATP (Figure 1C). In contrast to
Apaf-1(1–570), however, the ability of Apaf-1(1–
570M368L) to induce procaspase-9 activation was not
inhibited by the WDR (Figure 1C). We next incorporated
the M368L point mutation into full-length Apaf-1 and
determined the ability of wt and mutant Apaf-1 to activate
procaspase-9. In these experiments, we prepared cell
extracts from 293T cells transiently transfected with
Apaf-1 constructs and diluted the extracts so that
endogenous Apaf-1 activity could not be detected in the
procaspase-9 activation assay. Full-length Apaf-1 induced
activation of procaspase-9 in a dATP- and cytochrome c-
dependent manner (Figure 1D). In contrast, the point
mutant Apaf-1M368L activated procaspase-9 independent
of cytochrome c and dATP (Figure 1D). Apaf-1K160R,
a mutant substituting Lys160 [an essential amino acid
residue in the phosphate-binding loop (P-loop)] for Arg,
failed to activate procaspase-9 in the presence or absence
of dATP and cytochrome c (Figure 1D). This result
confirmed previous observations that dATP/ATP hydro-
lysis is required for Apaf-1 to induce procaspase-9
activation (Li et al., 1997).
The cytochrome c–Apaf-1 interaction requires ATP
hydrolysis
To determine the role for cytochrome c in procaspase-9
activation, we immunoprecipitated wt and mutant Apaf-1
from cytosolic extracts in the presence or absence of dATP
and assessed the binding of cytochrome c to Apaf-1
proteins by immunoblotting. Cytochrome c bound to
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Fig. 1. Mutation of Met368 to Leu renders Apaf-1 capable of activating procaspase-9 independent of cytochrome c and dATP. (A) Schematic
representation of the original Apaf-1 and Apaf-1XL. The 11 amino acids inserted after aa 98 are GKDSVSGITSY. The sequence of the extra 43 aa
was identical to that identified in an Apaf-1 cDNA that is deposited in the DDBJ/EMBL/GenBank database (accession No. AB007873).
(B) Mutation of Met368 to Leu decreases binding of Apaf-1(1–570) to WDR (WD-40 repeat region). pcDNA3 or plasmids encoding Myc-tagged
Apaf-1(1–570) or Apaf-1(1–570M368L) were transfected into 293T cells with a construct producing HA-tagged WDR (aa 479–1248 ). Total cell
lysates were immunoprecipitated with rabbit anti-c-Myc antibody and immune complexes were immunoblotted with anti-HA to detect the WDR. The
asterisk indicates a non-specific band. (C) WDR fails to inhibit Apaf-1(1–570M368L)-mediated procaspase-9 activation. Twenty micrograms of
cytosolic extracts containing indicated Apaf-1 mutants were incubated with in vitro translated [35S]methionine-labeled procaspase-9 at 30°C for
30 min and separated by SDS–PAGE. Immature and cleaved caspase-9 fragments were scanned and quantitated with a phosphoimager and
normalized according to the numbers of methionine residues in each form. Percentage of procaspase-9 converted into p35 is shown below each lane.
Lower panel shows equal amounts of Apaf-1 mutant proteins in extracts. (D) Mutation of Met368 to Leu renders full-length Apaf-1 capable of
activating procaspase-9 independent of cytochrome c and dATP. Two micrograms of extracts containing Apaf-1, Apaf-1M368L, or Apaf-1K160R
were incubated with or without 1 mM dATP and 0.2 μg of cytochrome c at 30°C for 30 min.
Fig. 2. Binding of cytochrome c to Apaf-1 requires dATP hydrolysis.
Cytosolic extracts containing Myc-tagged Apaf-1, Apaf-1M368L or
Apaf-1M368L/K160R were incubated with 10 μg/ml cytochrome c
with or without 1 mM dATP or ATP-γS in the presence of monoclonal
anti-Myc and protein A/G–agarose beads. After incubation at 4°C for
2 h, immunoprecipitation was performed as described in Materials and
methods and cytochrome c associated with Apaf-1 proteins detected by
immunoblotting. Wt and mutant Apaf-1 proteins precipitated from
cytosolic extracts are shown in the lower panel.
Apaf-1, and this binding was greatly enhanced by the
presence of dATP in the extract. Incubation of the
extracts with the non-hydrolyzable ATP-γS completely
abolished cytochrome c binding to wt Apaf-1, indicating
that dATP/ATP hydrolysis is essential for Apaf-1 to interact
with cytochrome c (Figure 2). The weak binding of
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cytochrome c to Apaf-1 detected in the absence of dATP
is presumably due to low levels of endogenous dATP/
ATP in the cell extract. In contrast, cytochrome c interacted
with Apaf-1M368L in the presence or absence of dATP
(Figure 2). Addition of ATP-γS failed to inhibit cytochrome
c binding to mutant Apaf-1M368L (Figure 2). Mutation
of Lys160 (the critical P-loop residue required for ATP
binding/hydrolysis) to Arg did not abolish the binding of
Apaf-1M368L to cytochrome c (Figure 2), providing
further evidence that cytochrome c can bind to Apaf-
1M368L independent of dATP binding and hydrolysis.
The diminished binding of cytochrome c to the double
mutant Apaf-1M368L/K160R, when compared with wt
Apaf-1 or Apaf-1M368L, could be explained by reduced
expression of the double mutant Apaf-1 protein in the
extract (Figure 2).
Apaf-1 self-association requires dATP/ATP
hydrolysis
It was previously reported that Apaf-1 requires dATP/ATP
to activate procaspase-9 (Li et al., 1997). dATP/ATP
hydrolysis could be required for Apaf-1 self-association
and/or the Apaf-1–procaspase-9 interaction, since a disrup-
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Fig. 3. Apaf-1 self-association requires cytochrome c and dATP hydrolysis. (A) Endogenous Apaf-1 binds Apaf-1(1–570) in the presence of
cytochrome c and dATP. Equal amounts of 293T cytosolic extracts containing Myc-tagged Apaf-1(1–570) were incubated with rabbit anti-Myc
antibody and protein A/G–agarose beads (1:1) under the indicated conditions at 4°C for 2 h. Then the beads were pelleted and washed four times
with 1 ml NP-40 buffer. ‘’ indicates that 5 mM ATP-γS was included in the extract. (B) Interaction of wt Apaf-1, Apaf-1M368L, Apaf-1K160R,
or Apaf-1M368L/K160R with Apaf-1(1–570). The experiments were performed as in (A) except that Apaf-1(1–570)-FLAG-containing extracts were
mixed with lysates containing Apaf-1, Apaf-1M368L, Apaf-1K160R, or Apaf-1M368L/K160R. Expression of wt and mutant Apaf-1 proteins in total
lysates is shown in lower panels. (C) Apaf-1M368L can associate with Apaf-1(1–570) independent of cytochrome c and dATP. Constructs producing
Apaf-1(1–570) and Apaf-1M368L were cotransfected into 293T cells and prepared total lysates were used for immunoprecipitation as described in (A).
tion of either step might be sufficient to inhibit
procaspase-9 activation (Hu et al., 1998b; Srinivasula
et al., 1998). We first determined whether dATP/ATP
hydrolysis is required for Apaf-1 self-association in cyto-
solic extracts. We transiently transfected 293T cells with
a Myc-tagged Apaf-1(1–570) construct and assessed its
interaction with endogenous Apaf-1 in the absence of
detergent. Immunoprecipitation experiments showed that
endogenous Apaf-1 associated with Apaf-1(1–570) in the
presence of cytochrome c and dATP, but not in the absence
of these factors (Figure 3A). The non-hydrolyzable ATP
analogue, ATP-γS, failed to substitute for dATP
(Figure 3A), indicating that ATP hydrolysis rather than
simple ATP binding is required for Apaf-1 to self-associate.
We next prepared extracts from cells transfected with wt
and mutant Apaf-1 constructs to analyze further the
requirement of dATP and/or cytochrome c for Apaf-1 self-
association. Immunoprecipitation analysis showed that
Apaf-1 self-association required both cytochrome c and
dATP (Figure 3B), in agreement with the results obtained
with endogenous Apaf-1. The constitutively active Apaf-
1M368L mutant associated with Apaf-1 in the absence of
cytochrome c, but required dATP for association with
Apaf-1(1–570) (Figure 3B). Mutation of the critical
P-loop Lys160 to Arg (M368L/K160R) abolished the
ability of Apaf-1M368L to associate with Apaf-1
(Figure 3B). When co-expressed with Apaf-1(1–570),
Apaf-1M368L interacted with Apaf-1(1–570) without the
addition of exogenous dATP (Figure 3C), suggesting that
intracellular dATP/ATP can promote their association.
Procaspase-9 binding to Apaf-1 requires dATP/ATP
hydrolysis
To examine the role of dATP/ATP hydrolysis in
procaspase-9 binding, we first determined whether dATP/
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ATP binding/hydrolysis is required for endogenous Apaf-1
to bind procaspase-9 in cytosolic extracts. We began by
transiently transfecting 293T cells with hemagglutinin
(HA)-tagged procaspase-9 (C287S) and assessing the
interaction of procaspase-9 with endogenous Apaf-1 in the
absence of detergent. Immunoprecipitation of procaspase-9
showed that endogenous Apaf-1 binds to procaspase-9 in
the presence of cytochrome c and dATP, but not in the
absence of these factors (Figure 4A). In addition, the
non-hydrolyzable ATP analogue, ATP-γS, inhibited
procaspase-9 binding to endogenous Apaf-1 (Figure 4A),
indicating that ATP hydrolysis is required for Apaf-1 to
bind procaspase-9. We next performed immunoprecipi-
tations with cytosolic extracts from cells transfected with
wt and mutant Apaf-1 constructs to further dissect the
requirement of dATP and/or cytochrome c for the binding
of procaspase-9 to Apaf-1. To avoid the formation of
Apaf-1 protein complexes in living cells, we prepared
cellular extracts expressing wt or mutant Apaf-1 and
incubated them with separately prepared extracts con-
taining procaspase-9 (C287S). As we showed with endo-
genous Apaf-1, exogenous Apaf-1 required both
cytochrome c and dATP to interact with procaspase-9
(Figure 4B). Mutation of Lys160 to Arg abolished
procaspase-9 binding to Apaf-1, confirming that dATP/
ATP hydrolysis is needed for the Apaf-1–procaspase-9
interaction. The constitutively active Apaf-1M368L
mutant interacted with procaspase-9 in the absence of
dATP and cytochrome c (Figure 4B), which is consistent
with the observation that this mutant does not require
these factors for activation of procaspase-9. Furthermore,
in contrast to endogenous Apaf-1, incubation with ATP-γS
did not inhibit the binding of mutant Apaf-1M368L to
procaspase-9 (data not shown). Surprisingly, mutation of
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Fig. 4. Cytochrome c and ATP hydrolysis are required for Apaf-1 to
interact with procaspase-9. (A) Procaspase-9 interacts with endogenous
Apaf-1 in a cytochrome c and dATP-dependent manner. Equal
amounts of 293T cytosolic extracts containing procaspase-9 (C287S)-
HA were incubated with rabbit anti-HA antibody and protein A/G–
agarose beads (1:1) under the indicated conditions at 4°C for 2 h.
Then the beads were pelleted and washed four times with 1 ml NP-40
buffer. ‘’ indicates that 5 mM ATP-γS was included in the extract.
(B) Procaspase-9 interacts with Apaf-1M368L in the absence of
cytochrome c and dATP. The experiments were performed as in (A)
except that procaspase-9(C287S)-HA-containing extracts were mixed
with lysates containing Apaf-1, Apaf-1M368L or Apaf-1K160R. (C) A
double-point mutant, Apaf-1M368L/K160R fails to interact with
procaspase-9. Expression of wt and mutant Apaf-1 proteins in total
lysates is shown in the lower panels in (B) and (C).
Lys160 to Arg abolished the ability of Apaf-1M368L to
interact with procaspase-9 (Figure 4C), suggesting that
dATP/ATP binding/hydrolysis is indeed required for this
point mutant to associate with procaspase-9. These appar-
ently conflicting data for the dATP/ATP requirement are
probably explained by the pre-formation of Apaf-1M368L
oligomeric complex within the cell after exposure to
endogenous dATP/ATP.
ATP hydrolysis is only required for a brief period of
time for Apaf-1 to activate procaspase-9
Next we performed experiments to determine whether
dATP/ATP hydrolysis is continuously required for Apaf-1-
mediated activation of procaspase-9. To do this, we
added the non-hydrolyzable ATP analog, ATP-γS, to the
procaspase-9 activation assay at various times, incubating
the reaction for a total of 30 min. As depicted in Figure 5,
procaspase-9 activation was greatly inhibited by ATP-γS
when added at the beginning of the reaction. ATP-γS
inhibited procaspase-9 activation by ~70% when added
after 10 s and by ~30% after 20 s (Figure 5). ATP-γS
minimally inhibited or could no longer inhibit procaspase-9
activation when it was added after 40 s (Figures 5). These
experiments suggest that dATP/ATP hydrolysis is required
for a brief period of time to activate procaspase-9.
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Fig. 5. dATP hydrolysis is only required for a short time in Apaf-1-
mediated procaspase-9 activation. Two micrograms of Apaf-1-
containing extract was mixed with 1 μl [35S]methionine-labeled
procaspase-9 on ice in the presence of 0.1 mM dATP and 0.2 μg of
cytochrome c. One millimolar ATP-γS was added to the reaction
mixture at different time intervals after the tubes containing reaction
mixtures were transferred into 30°C waterbath. The reaction was
incubated for a total of 30 min at 30°C. (A) Procaspase-9 activation
profile in the presence of ATP-γS when added at different times after
the beginning of the reactions. (B) Time course of inhibition of
procaspase-9 processing by ATP-γS. The amount of unprocessed and
processed caspase-9 (p35) forms were scanned and quantitated using a
phosphoimager. First, the amount of p35 processed forms was
normalized to full-length procaspase-9 and added to the corresponding
unprocessed procaspase-9 to obtain the total amount of procaspase-9
used in each lane. Then, p35 bands were normalized relative to total
procaspase-9 in each lane. Finally, normalized p35 fragments were
divided by the p35 fragment without ATP-γS (positive control).
Apaf-1M368L exhibits enhanced ability to induce
apoptosis
The experiments shown in Figure 1D indicate that the
Apaf-1M368L mutant can activate procaspase-9 indepen-
dently of cytochrome c. To determine the significance of
these findings for induction of apoptosis, we transiently
transfected wt and mutant Apaf-1 constructs into 293T
cells and assessed their ability to induce apoptosis 19 h
after transfection. Wt Apaf-1 failed to induce cell death
at low concentrations, but induced low-level apoptosis at
higher concentrations of plasmid DNA (Figure 6). In
contrast, Apaf-1M368L induced significant apoptosis even
at low levels of plasmid DNA and exhibited greater
proapoptotic activity than wt Apaf-1 at higher levels of
plasmid (Figure 6B). The P-loop mutant of Apaf-1
(K160R) deficient in Apaf-1 self-association and
procaspase-9 binding failed to induce apoptosis at all
concentrations of plasmid tested (Figure 6B). Apaf-
1M368L-induced apoptosis was effectively inhibited by a
catalytically inactive caspase-9 mutant (C287S) that acts
as a dominant-negative inhibitor (Figure 6B) (Li et al.,
1997; Pan et al., 1998), indicating that apoptosis induced
by Apaf-1M368L is caspase-9 dependent. Significantly,
the Apaf-1 double mutant, M368L/K160R, did not induce
apoptosis consistent with a requirement of dATP/ATP
hydrolysis for Apaf-1M168L to self-associate and binding
to procaspase-9 (Figure 6C).
Regulation of Apaf-1-mediated caspase-9 activation
Fig. 6. Induction of apoptosis by wt and Apaf-1 mutants. (A) Representative field of 293T cells transfected with 400 ng of indicated control and
Apaf-1 constructs and stained for β-galactosidase activity. Darker cells represent transfected and β-galactosidase-positive cells. The arrowheads
indicate round-up apoptotic cells with membrane blebbing. (B) Apaf-1M368L induces apoptosis in 293T cells. 293T cells were transiently
transfected with a reporter pcDNA3-galactosidase plus the indicated plasmids. The results represent the percentage of blue cells that exhibit
morphological features of apoptosis and are given as the mean SD of triplicate cultures. Casp9mt represents a catalytically inactive mutant of
procaspase-9 (C287S). (C) Apaf-1M368L/K160R failed to induce apoptosis. Four-hundred nanograms of indicated plasmids were used to transiently
transfect 293T cells as in (B).
Apaf-1(1–570) fails to induce apoptosis and
activate procaspase-3
Like the Apaf-1M368L mutant, Apaf-1 mutants lacking
the WDR can activate procaspase-9 independent of
cytochrome c and dATP (Figure 1C) (Hu et al., 1998a,b;
Srinivasula et al., 1998). Therefore, we compared the
ability of Apaf-1M368L and Apaf-1(1–570) to induce
apoptosis. Significantly, Apaf-1(1–570) did not kill 293T
cells while Apaf-1M368L induced significant apoptosis in
transfected cells (Figure 7A). Immunoblotting analysis
with anti-caspase-9 antibody showed that both Apaf-
1M368L and Apaf-1(1–570) induced processing of endo-
genous procaspase-9 into its signature p35 fragment
(Figure 7B, upper panel), indicating that the differential
activity of these Apaf-1 mutants cannot be explained by
lack of procaspase-9 activation. To assess the activation
of procaspase-3, a downstream caspase activated by
caspase-9, we immunoblotted the same extracts with anti-
caspase-3 antibody. Expression of Apaf-1M368L induced
processing of procaspase-3, as determined by the appear-
ance of the p18 subunit and reduction of procaspase-3
levels (Figure 7B, lower panel, reduced levels of
procaspase-3 could be observed in a shorter exposure;
data not shown). Significantly, procaspase-3 from cells
transfected with Apaf-1(1–570) remained unprocessed
even though procaspase-9 was cleaved (Figure 7B). Thus,
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the differential proapoptotic activity exhibited by the
constitutively active Apaf-1 mutants, Apaf-1(1–570) and
Apaf-1M368L, might be explained by the differential
processing of procaspase-3. To gain more insight into
this mechanism, we further assessed the activation of
procaspase-3 and procaspase-9 in cytosolic extracts pre-
pared from Apaf-1M368L and Apaf-1(1–570)-transfected
cells. In Apaf-1M368L extracts, procaspase-9 could be
effectively processed into the signature p35 proteolytic
fragment resulting from autoactivation of procaspase-9 and
p37, a fragment resulting from cleavage of procaspase-9 by
active caspase-3 (Figure 7C, upper panel) (Srinivasula
et al., 1998). In contrast, procaspase-9 was only cleaved
into p35 but not p37 in the Apaf-1(1–570) extract (Figure
7C), providing additional evidence that caspase-3 was not
activated in extracts expressing Apaf-1(1–570). To verify
this result, we assessed the processing of procaspase-3 in
the same extracts. The analysis confirmed that Apaf-
1M368L but not Apaf-1(1–570) promoted procaspase-3
activation (Figure 7C, lower panel).
Apaf-1M368L but not Apaf-1(1–570) can recruit
procaspase-3 to the Apaf-1–procaspase-9 complex
through procaspase-9
Next we wanted to determine the mechanism by which
procaspase-3 is activated in extracts from Apaf-1M368L
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Fig. 7. Apaf-1(1–570) fails to induce apoptosis and activate
procaspase-3. (A) Apaf-1(1–570) is unable to induce apoptosis of
293T cells. 293T cells were transiently transfected with a reporter
pcDNA3-galactosidase plus 0.4 μg of the indicated plasmids. The
results represent the percentage of blue cells that exhibit morpho-
logical features of apoptosis and are given as the mean SD of
triplicate cultures. (B) Procaspase-9 but not procaspase-3 is processed
in Apaf-1(1–570)-transfected 293T cells. Total cell lysates from 293T
cells as indicated in (A) were separated on SDS–PAGE gel and
immunoblotted for caspase-9 (upper panel) and caspase-3 (lower
panel). Molecular weight markers are indicated on the left of each
blot. (C) Both Apaf-1M368L and Apaf-1(1–570) can activate
procaspase-9 but only Apaf-1M368L is able to activate procaspase-3.
Forty micrograms of cytosolic extracts containing Apaf-1M368L or
Apaf-1(1–570) were incubated with [35S]methionine-labeled
procaspase-9 (upper panel) or procaspase-3 (lower panel) in the
absence of cytochrome c and dATP at 30°C for 30 min. Arrows
indicate immature and processed forms of caspase-9 (upper panel) and
caspase-3 (lower panel). p35 and p18 represent processed forms of
procaspase-9 and -3 respectively. Asterisks indicate non-specific bands.
transfected cells but not from those expressing Apaf-1(1–
570). One possibility we considered is that procaspase-3
could be recruited to the Apaf-1M368L–procaspase-9
complex but not to the Apaf-1(1–570)–procaspase-9
complex. To examine this, we immobilized various
Apaf-1 mutants on agarose beads in the presence or
absence of procaspase-9 and incubated the immobilized
Apaf-1 or Apaf-1–procaspase-9 complexes with in vitro
translated procaspase-3. In the absence of procaspase-9
(C2827S), procaspase-3 interacted weakly with Apaf-
1M368L, while procaspase-3 did not associate with
Apaf-1(1–570) or Apaf-1(479–1248) (Figure 8A). The
presence of procaspase-9 greatly enhanced the binding of
procaspase-3 to Apaf-1M368L (Figure 8A). In contrast,
procaspase-3 did not bind to Apaf-1(1–570) even in
the presence of procaspase-9 (Figure 8A). To determine
whether procaspase-3 interacts with procaspase-9 alone
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Fig. 8. Procaspase-3 is recruited into the Apaf-1–caspase-9 complex
but not into the Apaf-1(1–570)–caspase-9 complex. (A) Procaspase-3
is recruited into Apaf-1M368L–caspase-9 complex. Apaf-1 proteins
were immobilized on agarose beads and packed into gel filtration
columns as described in Materials and methods. In vitro-translated
[35S]methionine-labeled procaspase-3 was loaded onto the beads. After
extensive washing proteins bound to the beads were eluted, separated
by SDS–PAGE and transferred to nitrocellulose membrane.
(B) Procaspase-3 binds to procaspase-9 directly. Experiments were
performed as in (A) except procaspase-9 (C287S) was immobilized on
agarose beads. Procaspase-3 bound was detected by autoradiography
and Apaf-1 proteins and procaspase-9 (C287S) were detected by
immunoblotting. The upper panels show an autoradiograph of
procaspase-3 bound and amounts of bound procaspase-3 as quantitated
with a phosphoimager (procaspase-3 bound to control beads was
arbitrarily designated as 1). Apaf-1 proteins and procaspase-9 (C287S)
bound to beads were shown in lower two panels. Asterisks indicate
non-specific bands. H, immunoglobulin heavy chain; Cont., control
lysates transfected with pcDNA3.
or with the Apaf-1M368L–procaspase-9 complex, we
performed similar experiments with immobilized
procaspase-9 (Figure 8B). As shown in Figure 8B,
procaspase-3 did bind to procaspase-9 in the absence of
Apaf-1. Addition of Apaf-1M368L or wt Apaf-1 in the
presence of cytochrome c and dATP enhanced the binding
of procaspase-3 to immobilized procaspase-9 by 2- to 4-
fold (Figure 8B). This effect is presumably due to increased
recruitment of procaspase-9 to the complex by binding to
Apaf-1M368L or Apaf-1 in the presence of cytochrome c
and dATP. A direct interaction between procaspase-3
and procaspase-9 was also confirmed by co-immuno-
precipitation analysis (data not shown). Thus, wt Apaf-1
and Apaf-1M368L but not Apaf-1(1–570) can recruit
procaspase-3 to the Apaf-1–procaspase-9 complex through
procaspase-9.
Regulation of Apaf-1-mediated caspase-9 activation
Fig. 9. A model depicting the mechanism of apoptosome formation and procaspase-9 activation. Apaf-1 undergoes sequential conformational
changes induced by ATP hydrolysis and cytochrome c binding and acquires the ability to oligomerize. Subsequent binding of procaspase-9 to the
Apaf-1 oligomer results in recruitment of procaspase-3 and possibly procaspase-7 to this complex to form a functional apoptosome. Apaf-1M368L
may bypass the first two steps and adopts a conformation that is competent in oligomerizing and binding to procaspase-9 in the presence of dATP.
Alternatively, Apaf-1M368L may assume a conformation that bypasses cytochrome c binding but still requires a single dATP/ATP hydrolysis event
for oligomerization and procaspase-9 binding. This model is presented in greater detail in the Discussion.
Discussion
In this report we used Apaf-1 and various mutants to
elucidate the mechanism by which Apaf-1 mediates
procaspase-9 activation and induces apoptosis. Our studies
revealed that the binding of cytochrome c to Apaf-1
requires dATP/ATP hydrolysis. We also demonstrated that
two essential steps involved in procaspase-9 activation,
Apaf-1 self-association and procaspase-9 recruitment to
Apaf-1, require dATP/ATP hydrolysis and cytochrome c
binding to Apaf-1. These steps are important for proapop-
totic activity since Apaf-1 mutants deficient in dATP/ATP
hydrolysis or cytochrome c binding are impaired in their
ability to promote procaspase-9 activation and apoptosis.
Finally, we provide evidence that procaspase-3 is recruited
into the Apaf-1–procaspase-9 complex via interaction with
procaspase-9. The WDR may play an important role in the
recruitment of procaspase-3 to the Apaf-1–procaspase-9
complex, since mutant Apaf-1(1–570) lacking the WDR
can bind to procaspase-9 but cannot recruit procaspase-3
and is deficient in apoptosis.
Our observations that the WDR with an extra WD-40
repeat can interact with Apaf-1(1–570) and inhibit
activation of procaspase-9 mediated by Apaf-1(1–570)
(Figure 1B and C) support conclusions of our previous
paper obtained with the original Apaf-1 cDNA clone (Hu
et al., 1998b). Based on the results of our present study
and previous studies (Hu et al., 1998b; Srinivasula et al.,
1998), we provide a model depicting the events that lead
to the formation of a functional apoptosome (Figure 9). In
this model, dATP/ATP hydrolysis induces a conformational
change so that Apaf-1 acquires the ability to bind
cytochrome c. Upon cytochrome c binding, Apaf-1
undergoes further conformational changes to allow Apaf-1
oligomerization and CARD exposure. Procaspase-9 is
then recruited into Apaf-1 oligomers via CARD–CARD
homophilic interactions, and procaspase-3 is recruited
into the complex via interaction with procaspase-9.
Once recruited to the apoptosome, procaspase-9 is
activated via autocatalysis by Apaf-1 oligomerization-
induced proximity of multiple procaspase-9 molecules
(Hu et al., 1998b; Srinivasula et al., 1998). Procaspase-9
might be cleaved and activated by adjacent procaspase-9
molecules (intermolecular catalysis). Alternatively,
procaspase-9, forming part of the apoptosome, might
adopt a conformation that results in intramolecular
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cleavage. Activated caspase-9 then cleaves and activates
procaspase-3 recruited to the apoptosome. Once the
functional apoptosome is formed, dATP/ATP hydrolysis
would not longer be required for procaspase-9 recruitment,
activation or release of active caspase-9, as suggested by
our finding that dATP/ATP hydrolysis is only required for
a brief period of time in order for Apaf-1 to activate
procaspase-9. A model of Apaf-1 function that is consistent
with our findings has been proposed recently based on
studies with purified Apaf-1 and procaspase-9 proteins
(Zou et al., 1999).
In this study, we generated and characterized an Apaf-1
mutant that activates procaspase-9 independent of
cytochrome c. Apaf-1M368L constitutively self-associates
when synthesized in living cells. However, additional
mutation of Lys160 to Arg abrogated its ability to self-
associate and bind procaspase-9, as well as its capacity to
promote procaspase-9 activation and apoptosis. Although
the precise mechanism that accounts for its constitutional
activation remains to be determined, these results suggest
that Apaf-1M368L may bind and hydrolyze dATP/ATP
in vivo, and induce Apaf-1 oligomerization and procaspase-
binding and activation as intracellular dATP or ATP levels
are available in cells at concentrations of 10 μM and
10 mM, respectively (Skoog and Bjursell, 1974). The
ability of Apaf-1 to bind and hydrolyze dATP/ATP was
demonstrated by a recent paper that was published while
this paper was under review (Zou et al., 1999). In the
absence of dATP/ATP hydrolysis, the ability of wt Apaf-1
to oligomerize and to bind procaspase-9 might be
repressed by an interaction between its N-terminal region
and the WDR (Figure 1B and C) (Hu et al., 1998b).
One role of dATP/ATP hydrolysis might be to induce a
conformational change that enables cytochrome c to bind
Apaf-1. This hypothesis is supported by our finding
that cytochrome c binding to Apaf-1 requires dATP/ATP
hydrolysis. Binding of cytochrome c to the WDR may
disrupt or alter the negative interaction between the
N-terminal region and the WDR, allowing Apaf-1 to
oligomerize and to bind procaspase-9. This model is
supported by the analysis of the Apaf-1M368L mutant.
This mutant exhibited reduced interaction between the N-
terminal region and the WDR, bypassing the requirement
of cytochrome c to disrupt the negative interaction. The
lack of requirement for cytochrome c suggests that Apaf-
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1M368L spontaneously adopts a conformation that is
competent for oligomerization and procaspase-9 binding
in the presence of dATP/ATP. Mutation of Met368 to Leu,
therefore, might mimic conformational changes induced
by dATP hydrolysis and cytochrome c binding. Thus,
our findings that Apaf-1M368L still requires dATP/ATP
binding or hydrolysis suggest that a second dATP/ATP
binding or hydrolysis event may be required. Alternatively,
Apaf-1M368L may assume a conformation that bypasses
cytochrome c binding but still requires a single dATP/
ATP hydrolysis event for oligomerization and procaspase-9
binding. CED-4, the C.elegans homologue of Apaf-1,
lacks the WDR implying that CED-4 could constitutively
activate CED-3, unless repressed by its physical asso-
ciation with CED-9. This model is supported by genetic
analysis of C.elegans that showed that loss-of-function
mutants of ced-9 are lethal due to increased developmental
cell deaths, but can be rescued by loss-of-function
mutations in ced-4 (Hengartner et al., 1992). Furthermore,
biochemical experiments in mammalian cells have
revealed that the ability of CED-4 to activate CED-3
is inhibited by the association of CED-9 with CED-4
(Seshagiri and Miller, 1997; Wu et al., 1997b). Interest-
ingly, the equivalent position of Met368 is conserved in
mouse Apaf-1 but is a leucine residue in CED-4. These
observations suggest that cytochrome c is probably not a
factor required for CED-4-mediated CED-3 activation.
However, additional studies to test this hypothesis need
to be performed in C.elegans.
Apaf-1M368L acts as a gain-of-function mutation in
that, unlike wt Apaf-1, it activates procaspase-9 independ-
ent of cytochrome c and dATP in vitro and exhibits
enhanced ability to induce apoptosis in vivo. In contrast,
another mutant, Apaf-1(1–570), activates procaspase-9
independent of cytochrome c and dATP in vitro, but fails
to induce apoptosis. Our results indicate that procaspase-9
complexed with Apaf-1M368L, but not procaspase-9
complexed with Apaf-1(1–570), can recruit and activate
procaspase-3, providing an explanation for the differential
phenotypes. Our studies support a model whereby
procaspase-3 is recruited into the apoptosome formed by
the Apaf-1–procaspase-9 complex via its interaction with
procaspase-9. Apaf-1(1–570) lacking the WDR binds and
activates procaspase-9 suggesting that its inability to
recruit procaspase-3 is independent of these activities.
Several possibilities could be envisioned to explain these
results. First, conformational changes in the procaspase-9
bound to wt Apaf-1 and Apaf-1M368L could be critical
for the recruitment of procaspase-3. Procaspase-9 bound
to Apaf-1(1–570) might assume a conformation that is
unsuitable for procaspase-3 recruitment. Another possi-
bility is that the WDR, which is lacking in Apaf-1
(1–570), might be involved in the recruitment of
procaspase-3 to the Apaf-1–procaspase-9 complex. In the
absence of the WDR, Apaf-1(1–570) may be unable to
induce the conformational changes of procaspase-9
required for recruitment of procaspase-3.
The cytochrome c/Apaf-1/caspase-9/caspase-3 pathway
is now known to contribute to apoptosis induced by
various stresses, including UV and γ-irradiation and
chemotherapeutic drugs (Hakem et al., 1998; Yoshida
et al., 1998). In addition, inactivation of either Apaf-1 or
caspase-9 in this pathway contributes to cellular trans-
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formation and tumorigenesis (Soengas et al., 1999). Under
normal conditions, cytochrome c is unavailable to induce
procaspase-9 activation since it resides in the inter-
membrane space of the mitochondria. After apoptotic
stimuli lead to mitochondrial damage, cytochrome c is
released and can activate procaspase-9 in an Apaf-1-
dependent manner (Zou et al., 1997; Fearnhead et al.,
1998). Prosurvival Bcl-2 family members are over-
expressed in many tumors and inhibit caspase-9-mediated
apoptosis by binding and inhibiting procaspase-9
activation directly and/or preventing the release of
cytochrome c from mitochondria (Kharbanda et al., 1997;
Kim et al., 1997; Kluck et al., 1997; Yang et al., 1997;
Hu et al., 1998a). Therefore, it will be interesting to
examine whether prosurvival Bcl-2 family members like
Bcl-XL can directly inhibit Apaf-1M368L-mediated
procaspase-9 activation. If Bcl-XL can no longer exert its
inhibitory effect on Apaf-1M368L-mediated activation of
procaspase-9, the ability of Apaf-1M368L to activate
procaspase-9 in the absence of cytochrome c could provide
a potential method of inducing apoptosis in cancer cells
in which cytochrome c release is blocked by overexpres-
sion of anti-apoptotic members of the Bcl-2 family.
Materials and methods
Plasmids and reagents
The Apaf-1XL cDNA was isolated by RT–PCR amplification from RNA
template isolated from 293T cells and cloned into the pcDNA3 plasmid.
The nucleotide sequence of the Apaf-1XL cDNA has been submitted
to the DDBJ/EMBL/GenBank database (accession No. AF149794).
pcDNA3-Apaf-1XL-M368L and pcDNA3-Apaf-1XL-K160R were gen-
erated by replacing the BstEII–EcoRV fragment of pcDNA3-Apaf-1XL
with the corresponding fragments from pcDNA3-Apaf-1(1–559M357L)
and pcDNA3-Apaf-1(1–559K149R), respectively (Hu et al., 1998b).
pcDNA3-Apaf-1XL-M368L/K160R was constructed by ligation of a
BstEII–XbaI fragment from pcDNA3-Apaf-1(1–559K149R) and a XbaI–
EcoRV fragment from pcDNA3-Apaf-1(1–559M357L) into BstEII–
EcoRV-digested pcDNA3-Apaf-1XL. All the constructs were verified by
nucleotide sequencing. Polyclonal anti-Apaf-1 antibody was kindly
provided by Xiaodong Wang, Southwestern Medical School, Dallas, TX.
Polyclonal anti-caspase-9 and anti-caspase-3 antibodies were gifts from
Donald Nicholson (Merck).
Transfection, immunoprecipitation and Western blot
analysis
Human embryonic kidney 293T cells (2–5106) were transfected with
5 μg of the indicated plasmid DNA by the calcium phosphate method
as reported (Inohara et al., 1997). Cytosolic extracts were made essentially
as described previously (Hu et al., 1998a). Protein immunoprecipitation
and Western blot analysis with relevant antibodies were performed as
described previously (Inohara et al., 1997). The proteins were detected
by an enhanced chemiluminescence system (ECL; Amersham).
In vitro caspase-9 and caspase-3 assay
Cytosolic extracts were prepared and stored frozen at –80°C.
Procaspase-9 was translated in vitro from a pcDNA3-caspase-9 plasmid
in the presence of [35S]methionine (Amersham) with a Promega TNT
transcription/translation kit and purified through a desalting column free
of radioactive methionine and ATP (Pharmacia). Procaspase-3 was
translated in vitro using the same kit. To avoid contaminating dATP/
ATP from cytosolic extracts in testing cytochrome c and dATP-dependent
activation of procaspase-9 by Apaf-1 proteins, the cytosolic extracts
were passed through a desalting column (Pharmacia). We incubated 2 μg
(Figures 1D and 5A) or 40 μg (Figure 7C) of cellular extracts with or
without dATP (1 mM) or bovine cytochrome c (0.2 μg, Sigma) in the
presence of 1 μl in vitro translated procaspase-9 in a final volume of
25 μl. The mixtures were incubated for 30 min at 30°C and the reactions
stopped by adding 5 SDS loading buffer and boiling for 5 min.
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Apoptosis assay
293T cells (1105) were seeded in each well of 12-well plates. After
18 h, cells were transiently transfected with 0.2 μg of the reporter
pcDNA3-galactosidase plasmid plus indicated amount of test plasmids,
as reported (Hu et al., 1998a). pcDNA3 was used to adjust total plasmid
DNA to an equal amount. The percentage of apoptotic cells was
determined 19 h after transfection in triplicate cultures as described
previously (Hu et al., 1998a).
Procaspase-3 recruitment assay
Cytosolic extracts containing Myc-tagged Apaf-1 proteins and control or
caspase-9 extracts were incubated with either anti-c-Myc (to immobilize
Apaf-1 protein) or anti-HA (to immobilize procaspase-9) antibodies and
protein A/G–agarose beads (1:1) for 2 h. The beads were washed three
times with 1 ml NP-40 buffer (Inohara et al., 1997) and once with 1 ml
buffer A (Hu et al., 1998a). Apaf-1- or procaspase-9-coated beads were
packed into disposable gel filtration columns. Then in vitro translated
caspase-3 was loaded onto the beads and washed four times with 1 ml
buffer A. Bound proteins were eluted with 50 μl of hot 1 SDS loading
buffer. We quantitated bound caspase-3 using a PhosphorImager from
Molecular Dynamics.
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Wu,D., Wallen,H.D. and Núñez,G. (1997b) Interaction and regulation of
subcellular localization of CED-4 by CED-9. Science, 275, 1126–1129.
Yang,J., Liu,X., Bhalla,K., Kim,C.N., Ibrado,A.M., Cai,J., Peng,T.I.,
Jones,D.P. and Wang,X. (1997) Prevention of apoptosis by Bcl-2:
release of cytochrome c from mitochondria blocked. Science, 275,
1129–1132.
Yang,X., Chang,H.Y. and Baltimore,D. (1998) Essential role of CED-4
oligomerization in CED-3 activation and apoptosis. Science, 281,
1355–1357.
Yoshida,H., Kong,Y.Y., Yoshida,R., Elia,A.J., Hakem,A., Hakem,R.,
Penninger,J.M. and Mak,T.W. (1998) Apaf1 is required for
mitochondrial pathways of apoptosis and brain development. Cell, 94,
739–750.
Yuan,J. (1996) Evolutionary conservation of a genetic pathway of
programmed cell death. J. Cell. Biochem., 60, 4–11.
Zou,H., Henzel,W.J., Liu,X., Lutschg,A. and Wang,X. (1997) Apaf-1, a
human protein homologous to C. elegans CED-4, participates in
cytochrome c-dependent activation of caspase-3. Cell, 90, 405–413.
Zou,H., Li,Y., Liu,X. and Wang,X. (1999) An APAF-1–cytochrome c
multimeric complex is a functional apoptosome that activates
procaspase-9. J. Biol. Chem., 274, 11549–11556.
Received April 26, 1999; revised and accepted May 18, 1999
